CreditReports.dk
HomeScreen companies

PULMOPHARMA ApS Financials, key figures and credit report

CVR number: 36428023 Established 2014 Industry: 72 Scientific research and development
Company contact details
Bøgebjerg 2, 8400 Ebeltoft
Gross profit -49.4 kDKK FY 2025 -140.8% vs 2024
EBIT -49.4 kDKK FY 2025 -140.8% vs 2024
Net debt -1 120.9 kDKK FY 2025 -181.6% vs 2024
Quick ratio 1.8 FY 2025 +0.7 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit-80.38-56.50-47.30-20.50-49.35
EBIT-80.38-56.50-47.30-20.50-49.35
Other financial expenses-12.72-6.33
Pre-tax profit-93.10-62.83-47.30-20.50-49.35
Net earnings-93.10-62.83-47.30-20.50-49.35

Assets (kDKK)

2021
2022
2023
2024
2025
Development expenditure882.533 965.165 173.247 198.679 775.35
Intangible assets total882.533 965.165 173.247 198.679 775.35
Tangible assets total
Investments total
Long term receivables total
Inventories total
Prepayments and accrued income1 598.01887.78177.562 090.251 281.12
Current other receivables96.3881.6644.3819.9814.48
Short term receivables total1 694.39969.44221.932 110.231 295.60
Cash and bank deposits1 409.6018.873 501.2216.982 510.84
Cash and cash equivalents1 409.6018.873 501.2216.982 510.84
Balance sheet total (assets)3 986.524 953.478 896.399 325.8913 581.79

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital40.0040.0046.6746.6747.95
Share premium account3 963.003 963.007 956.337 956.3312 060.25
Retained earnings- 398.18- 491.29- 554.12- 601.41- 621.91
Profit of the financial year-93.10-62.83-47.30-20.50-49.35
Shareholders equity total3 511.723 448.897 401.597 381.0911 436.93
Non-current liabilities total
Current trade creditors7.3714.704.924.924.92
Current owed to participating467.441 039.891 039.891 389.891 389.89
Other non-interest bearing current liabilities450.00450.00550.00750.05
Current liabilities total474.801 504.581 494.801 944.802 144.85
Balance sheet total (liabilities)3 986.524 953.478 896.399 325.8913 581.79
Page generated